The transaction would have valued PacBio at $1.2 billion.
This will be a great year for life sciences tools and diagnostics companies, says Bryan Brokmeier of Maxim Group. And no, growth won't be driven by irrational exuberance, the senior analyst
At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.
| Website: | www.pacb.com |
| Email: | ir@pacificbiosciences.com |
| Main Phone: | +1 650 521-8000 |
| Address: | 1305 O'Brien Drive |
| State: | CA |
| City / Town: | Menlo Park |
| Country: | US |
| Postal Code: | 94025 |
| Exchange: | NGS |
| CEO: | Christian O. Henry |
| Employees: | 412 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
The transaction would have valued PacBio at $1.2 billion.
This will be a great year for life sciences tools and diagnostics companies, says Bryan Brokmeier of Maxim Group. And no, growth won't be driven by irrational exuberance, the senior analyst
At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
Advanced GDP for the third quarter came in a 2.0%. A month from now we get the preliminary report then a month later the final number. University of Michigan consumer sentiment came in at 82.6 in
Recent economic data points and the Beige Book favored steady economic growth, but this morning’s data counters this positive information. Initial Jobless Claims rose 27,000 last week to 399,000
The minutes from the last FOMC meeting stated that the Federal Reserve’s monetary policy alone would not turn the economy around. The Dow Jones Industrial Average surged to 11,552.76 on
There were no economic data points on Tuesday and tomorrow we get the minutes of the last FOMC meeting. The Dow Jones Industrial Average, which closed at 11,433 on Monday dipped to 11,365.67 on
The Labor Department reported that the Unemployment Rate remained at 9.1% in September. Meanwhile the economy added 103,000 jobs, which was better than expected, but below levels of enough job
Challenger, Grey and Christmas reported that planned layoffs rose to 115,730 in September to levels not seen since April 2009. ADP reported to the contrary that the private sector added 91,000
Next week the economic data releases include New Home Sales on Monday, Consumer Confidence on Tuesday, Durable Goods Orders on Wednesday, the final reading of Q2 GDP on Friday, and Personal Income
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
